Letters A/H1N1 flu pandemic

Antiviral drugs: distinguish treatment from prophylaxis

BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3620 (Published 08 September 2009) Cite this as: BMJ 2009;339:b3620
  1. Benjamin J Cowling, assistant professor1,
  2. Sophia Ng, doctoral student1,
  3. Ira M Longini Jr, professor2
  1. 1School of Public Health, University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
  2. 2Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
  1. bcowling{at}hku.hk

    Shun-Shin and colleagues provide a timely review of the effectiveness of neuraminidase inhibitors for treatment and chemoprophylaxis of flu virus infections.1 As the pandemic A/H1N1 flu virus seems to have remained susceptible in vitro to neuraminidase inhibitors we expect that effectiveness against the pandemic virus would be similar to that against seasonal …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe